Cypre Status
The company raised $150,000 of convertible debt funding from undisclosed investors on August 24, 2018. Earlier, the company raised an undisclosed amount of venture funding from Hemi Ventures on January 1, 2017.
Developer of a tumor microenvironment system intended to be used for the transformative 3D cellular research and clinical testing of cancer patients. The company's tumor microenvironment system consists of extracellular matrix remodeling, immune infiltration and other processes that influence tumor progression, enabling medical institutions with better and advanced drugs, opening the door for a new generation of therapeutics and patient success.
Year Founded
2016
General Information
-
Website
-
Business Status
Generating Revenue
-
Ownership Status
Privately Held (backing)
-
Financing Status
Venture Capital-Backed
Cypre News and Updates
Campbell 'excited' about bpTT presidency
TT Newsday | October 3, 2022
BP Trinidad and Tobago Cypre offshore gas project gets go-ahead - Splash247
Splash 247 | September 29, 2022
How fracking and oil sands go together
TT Newsday | September 28, 2022
Cypre project gets go ahead
BNamericas English | September 23, 2022
Racecard | 15:45 P. & B. Cypres Hurdle | Auteuil (FR)
Sky Sports | September 12, 2022
Tutu Church of God Academy student graduates at age 14
Virgin Islands Daily News | June 17, 2022
Cypre's Verticals
Cypre Primary Industry Sector / Group / Code
Cypre's Trends
Cypre Metrics
Majestic Referring Domains
Headquarters
-
HQ Address Line 1953 Indiana Street
-
HQ CitySan Francisco
-
HQ State/ProvinceCalifornia
-
HQ Post Code94107
-
HQ CountryUnited States
Cypre's Keywords
mood_badFeed is empty.
Add a review